Compass Therapeutics
  • Home
  • About
  • Platform
  • Pipeline
  • Join Us
  • News
  • Investors
  • Contact

News

Press releases

December 2, 2019
Compass Therapeutics to Present at Piper Jaffray 31st Annual Healthcare Conference
October 24, 2019
Compass Therapeutics to Present Preclinical Data on a Novel PD-1/PD-L1 Bispecific Antibody and from its Proprietary Innate Cell Engager Platform at the 2019 SITC Meeting
October 22, 2019
Compass Therapeutics Appoints Leading Immuno-Oncology Researchers to Its Immuno-Oncology Scientific Advisory Board
August 1, 2019
Compass Therapeutics Appoints Julie Sunderland to Board of Directors
July 8, 2019
Compass Therapeutics Announces First Patient Dosed in Phase 1 Trial of CTX-471
June 17, 2019
Compass Therapeutics Announces Issuance of Composition of Matter and Method Patents Covering Its Lead Immuno-oncology Candidate, CTX-471
March 24, 2019
Compass at Keystone’s Cancer Immunotherapy Symposium (March 24-28) in Keystone, Colorado
March 12, 2019
Compass at the Cowen & Co. 39th Annual Health Care Conference 2019
January 3, 2019
Compass Therapeutics to Present at J.P. Morgan Healthcare Conference
  • © 2021 Compass Therapeutics, Inc.
  • Terms & Conditions
  • Privacy Policy
  • Home
  • About
  • Platform
  • Pipeline
  • Join Us
  • News
  • Contact
  • Investors